Novartis Foundation Symposium 209 – Oligonucleotides as Therapeutic Agents

C Ciba (Autor)

Software / Digital Media

260 Seiten

2007
Wiley-Blackwell (Hersteller)
978-0-470-51539-6 (ISBN)

Keine Verlagsinformationen verfügbar

Artikel merken

The use of oligonucleotides as therapeutic agents rests upon their ability to interfere, in a sequence-specific manner, with the fundamental machinery of protein synthesis either by binding to the mRNAs transcribed from a gene or by binding directly to a target gene. This approach can be used not only for inhibition of the synthesis of host proteins but also of those required by invading pathogens. Potential therapeutic applications are enormous, ranging over hypertension, cardiovascular disease, autoimmune disease, vital and other parasitic infections (especially HIV), and cancer. This book discusses the chemistry and pharmacokinetics of oligonucleotides and their analogues, and surveys the results of structure-activity studies and current clinical trials. It also critically reviews the problems with antisense therapy, such as the enzymatic destruction of oligonucleotides, the doses required for a therapeutic response, the difficulty in directing oligonucleotides to particular target tissues and cells, the need for parenteral administration, and doubts concerning the mechanism of action (especially problems associated with non-specific binding to proteins) and long-term effects.

Derek J. Chadwick and Gail Cardew are editors for Oligonucleotides as Therapeutic Agents and other scientific titles.

Oligonucleotide Analogues: An Overview; Phosphorothioate Oligodeoxynucleotides: Large Scale Synthesis and Analysis, Impurity Characterization and the Effects of Phosphorous Stereochemistry; Discovering Antisense Reagents by Hybridization of RNA to Oligonucleotide Arrays; Pharmacokinetics of Oligonucleotides in Cell Culture; Pharmacokinetics of Antisense Oligonucleotides; Cellular Pharmacology of Antisense Oligodeoxynucleotides; Sequence -Specific Control of Gene Expression by Antigene and Clamp Oligonucleotides; Differential Oligonucleotide Activity in Cell Culture Versus Mouse Models; Structure-Activity Relationships in Cell Culture; Progress in Antisense Therapeutics; Treating Human Myelogenous Leukaemia With Oligonucleotides Targeted to the C-Myb Gene: Two Years Clinical Experience; Therapeutic Applications of Catalytic Antisense RNAs; Exogenous Application of Ribozymes for the Inhibition of Gene Expression; SELEX Derived Drugs; In Vivo Production of Oligonucleotide Applications for Antisense DNA.

Erscheint lt. Verlag	28.9.2007
Verlagsort	Hoboken
Sprache	englisch
Maße	155 x 235 mm
Gewicht	540 g
Themenwelt	Naturwissenschaften ► Chemie
ISBN-10	0-470-51539-2 / 0470515392
ISBN-13	978-0-470-51539-6 / 9780470515396
Zustand	Neuware